Uveal effusion syndrome associated with primary pulmonary hypertension and vomiting

American Journal of Ophthalmology
L AkdumanT Meredith

Abstract

We treated a 69-year-old woman with bilateral uveal effusions associated with primary pulmonary hypertension, congestive heart failure, and vomiting. The patient underwent ophthalmoscopic, echocardiographic, and fluorescein angiographic examinations. Increased venous pressure caused by congestive heart failure and vomiting was implicated as the cause of bilateral uveal effusions. The uveal effusions responded well to systemic furosemide. Primary pulmonary hypertension with right-sided congestive heart failure and vomiting can lead to the development of uveal effusions.

References

Mar 1, 1983·Survey of Ophthalmology·R F Brubaker, J E Pederson

❮ Previous
Next ❯

Citations

Oct 7, 2006·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Yumi SuzukiNoriyuki Azuma
Jun 12, 2009·Journal français d'ophtalmologie·H OffretO Offret
Apr 30, 2003·American Journal of Ophthalmology·Jørgen Krohn, Christian Bjune
Jan 22, 2017·International Ophthalmology·Zhuolei FengDaohong Lin
Aug 3, 2004·Eye·F M Cuthbertson, M McKibbin
Feb 17, 2007·Clinical Transplantation·Maha A AssiRaymund R Razonable
Apr 1, 2010·Retinal Cases & Brief Reports·Márcio B NehemyDaniel V Vasconcelos-Santos
Jun 6, 2006·Ophthalmic Surgery, Lasers & Imaging : the Official Journal of the International Society for Imaging in the Eye·Sungjae YangYoung H Yoon

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.